[ FDA DRUG SHORTAGES TRACKER ]

A drug shortage is a quality failure with a body count.

Live FDA drug shortage data (openFDA), grouped by status, availability, and therapeutic area. The FDA’s own root-cause analysis puts manufacturing and quality problems at the centre of the shortage crisis — which is why SPEQ treats the shortage list as a quality-system signal, not just a supply-chain one.

1,000
Active shortages tracked
852
Current
147
To be discontinued
212
Flagged unavailable
21% flagged unavailable · latest update 2026-07-30 · source: openFDA drug/shortages
NEW SHORTAGES POSTED · MONTHLY

By initial FDA posting date. openFDA lists active shortages, so older cohorts thin as entries resolve.

ACTIVE SHORTAGES BY THERAPEUTIC CATEGORY · TOP 10
WHY THIS SITS UNDER QUALITY, NOT LOGISTICS

The FDA’s 2019 report Drug Shortages: Root Causes and Potential Solutions found the dominant drivers are not scarcity of raw materials but a lack of incentives to produce, and manufacturing/quality problems that force production to stop. Mature quality systems — the difference a QMM assessment measures — are what keep a line running.

The economics of quality →FDA QMM framework →
Reset
1,178 matching shortages
DrugCompanyTherapeutic areaAvailabilityStatusPosted
Phenobarbital TabletTabletEndo Pharmaceuticals, Inc.Analgesia/AddictionTo Be Discontinued2025-10-31
Phenobarbital TabletTabletEndo Pharmaceuticals, Inc.Analgesia/AddictionTo Be Discontinued2025-10-31
Phenobarbital TabletTabletEndo Pharmaceuticals, Inc.Analgesia/AddictionTo Be Discontinued2025-10-31
Phenobarbital TabletTabletEndo Pharmaceuticals, Inc.Analgesia/AddictionTo Be Discontinued2025-10-31
Phenobarbital TabletTabletEndo Pharmaceuticals, Inc.Analgesia/AddictionTo Be Discontinued2025-10-31
Phenobarbital TabletTabletEndo Pharmaceuticals, Inc.Analgesia/AddictionTo Be Discontinued2025-10-31
Moxifloxacin InjectionInjectionFresenius Kabi USA, LLCAnti-InfectiveTo Be Discontinued2025-10-29
Pramlintide Acetate InjectionInjectionAstraZeneca ABEndocrinology/MetabolismTo Be Discontinued2025-10-27
Pramlintide Acetate InjectionInjectionAstraZeneca ABEndocrinology/MetabolismTo Be Discontinued2025-10-27
Busulfan InjectionInjectionMylan Institutional, a Viatris CompanyHematologyTo Be Discontinued2025-10-24
Insulin Lispro-aabc InjectionInjectionEli Lilly and Co.Endocrinology/MetabolismTo Be Discontinued2025-10-24
Insulin Glargine InjectionInjectionEli Lilly and Co.Endocrinology/MetabolismTo Be Discontinued2025-10-24
Insulin Lispro-aabc InjectionInjectionEli Lilly and Co.Endocrinology/MetabolismTo Be Discontinued2025-10-24
Insulin Lispro InjectionInjectionEli Lilly and Co.Endocrinology/MetabolismTo Be Discontinued2025-10-24
Tranylcypromine Sulfate TabletTabletTeva Pharmaceuticals USA, Inc.PsychiatryTo Be Discontinued2025-10-21
Oxaliplatin InjectionInjectionSandoz Inc.OncologyTo Be Discontinued2025-10-20
Oxaliplatin InjectionInjectionSandoz Inc.OncologyTo Be Discontinued2025-10-20
Elbasvir; Grazoprevir TabletTabletMerck Sharp & Dohme LLCAntiviralTo Be Discontinued2025-10-17
Vigabatrin Oral SolutionOral SolutionPyros Pharmaceuticals, Inc.NeurologyTo Be Discontinued2025-10-16
Voriconazole InjectionInjectionPfizer Inc.AntiviralTo Be Discontinued2025-10-16
Pemetrexed Disodium InjectionInjectionEli Lilly and Co.OncologyTo Be Discontinued2025-10-16
Pemetrexed Disodium InjectionInjectionEli Lilly and Co.OncologyTo Be Discontinued2025-10-16
Pemetrexed Disodium InjectionInjectionSandoz Inc.OncologyTo Be Discontinued2025-10-10
Pemetrexed Disodium InjectionInjectionSandoz Inc.OncologyTo Be Discontinued2025-10-10
Omeprazole Delayed Release CapsuleSandoz Inc.GastroenterologyTo Be Discontinued2025-10-09
Page 47 of 48
← PrevNext →

Data: U.S. FDA openFDA drug/shortages API, which lists activeshortages (Current or To Be Discontinued) — it carries no per-record cause field, so SPEQ makes no root-cause claim on individual drugs; the quality framing above is cited FDA context. openFDA publishes shortage data for drugs only; SPEQ’s cross-industry coverage lives in the recall Explorer(drug, device & food).